<VariationArchive VariationID="1454791" VariationName="NM_015295.3(SMCHD1):c.3274_3276+1del" VariationType="Deletion" Accession="VCV001454791" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2022-03-28" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1445127" VariationID="1454791">
      <GeneList>
        <Gene Symbol="SMCHD1" FullName="structural maintenance of chromosomes flexible hinge domain containing 1" GeneID="23347" HGNC_ID="HGNC:29090" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18p11.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="2655726" stop="2805017" display_start="2655726" display_stop="2805017" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="2655885" stop="2805014" display_start="2655885" display_stop="2805014" Strand="+" />
          </Location>
          <OMIM>614982</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015295.3(SMCHD1):c.3274_3276+1del</Name>
      <CanonicalSPDI>NC_000018.10:2732489:AAAG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18p11.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="2732490" stop="2732493" display_start="2732490" display_stop="2732493" variantLength="4" positionVCF="2732489" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="2732488" stop="2732491" display_start="2732488" display_stop="2732491" variantLength="4" positionVCF="2732487" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.2732490_2732493del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.2732490_2732493del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.2732488_2732491del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.2732488_2732491del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031972.1" sequenceAccession="NG_031972" sequenceVersion="1" change="g.81603_81606del">
            <Expression>NG_031972.1:g.81603_81606del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015295.3" sequenceAccession="NM_015295" sequenceVersion="3" change="c.3274_3276+1del" MANESelect="true">
            <Expression>NM_015295.3:c.3274_3276+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015295.2" sequenceAccession="NM_015295" sequenceVersion="2" change="c.3274_3276+1delAAAG">
            <Expression>NM_015295.2:c.3274_3276+1delAAAG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2075161459" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015295.3(SMCHD1):c.3274_3276+1del AND Facioscapulohumeral muscular dystrophy 2" Accession="RCV001939584" Version="5">
        <ClassifiedConditionList TraitSetID="9087">
          <ClassifiedCondition DB="MedGen" ID="C1834671">Facioscapulohumeral muscular dystrophy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015295.3(SMCHD1):c.3274_3276+1del AND Inborn genetic diseases" Accession="RCV002569139" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23143600</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25256356</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25370034</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27061275</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9087" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1266" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B</ElementValue>
                <XRef Type="MIM" ID="158901" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC</ElementValue>
                <XRef Type="MIM" ID="158901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614982.0017" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FSHD2, DIGENIC</ElementValue>
                <XRef Type="MIM" ID="158901" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Facioscapulohumeral muscular dystrophy 2</ElementValue>
                <XRef ID="MONDO:0008031" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FSHD2</ElementValue>
                <XRef Type="MIM" ID="158901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSHD1B</ElementValue>
                <XRef Type="MIM" ID="158901" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexors of the foot. Severity is highly variable. Weakness is slowly progressive and approximately 20% of affected individuals eventually require a wheelchair. Life expectancy is not shortened.</Attribute>
                <XRef ID="NBK1443" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15088" />
                <XRef ID="15088" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301616</ID>
                <ID Source="BookShelf">NBK1443</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN/AANEM, 2015">
                <ID Source="pmc">4520817</ID>
              </Citation>
              <XRef ID="269" DB="Orphanet" />
              <XRef ID="C1834671" DB="MedGen" />
              <XRef ID="MONDO:0008031" DB="MONDO" />
              <XRef Type="MIM" ID="158901" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4246487" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3392365|MedGen:C1834671" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002227794" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25256356</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27061275</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant is associated with skipping of exon 25 but is expected to preserve the integrity of the reading frame (25256356). This variant has been observed in individual(s) with facioscapulohumeral muscular dystrophy 2 (PMID: 25256356, 27061275). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (ExAC no frequency). This variant results in the deletion of part of exon 25 (c.3274_3276+1del) of the SMCHD1 gene. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMCHD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.2732488_2732491del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1834671" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6239894" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a9663597|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003552468" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23143600</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25370034</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27061275</ID>
          </Citation>
          <Comment>The c.3274_3276+1delAAAG intronic variant results from a deletion of 4 nucleotides between nucleotide positions c.3274 and c.3276+1 of the SMCHD1 gene. Alterations that disrupt the canonical splice site are expected to result in aberrant splicing. The resulting transcript is predicted to be in-frame and is not expected to trigger nonsense-mediated mRNA decay; however, direct evidence is unavailable. The exact functional effect of the altered amino acid sequence is unknown; however, the impacted region is critical for protein function and a significant portion of the protein is affected. Based on data from the Genome Aggregation Database (gnomAD), the SMCHD1 c.3274_3276+1delAAAG alteration was not observed, with coverage at this position. This alteration has been reported in multiple unrelated patients with facioscapulohumeral muscular dystrophy type 2 (FSD2) (Lemmers, 2012; Larsen, 2015; Hamanaka, 2016). The patients also were found to have hypomethylation of the DUX4 gene on chromosome 4, consistent with digenic inheritance of FSD2. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and may result in the creation or strengthening of a novel splice donor site. Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMCHD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015295.2:c.3274_3276+1delAAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4246487" TraitType="Disease" MappingType="XRef" MappingValue="C1834671" MappingRef="MedGen">
        <MedGen CUI="C1834671" Name="Facioscapulohumeral muscular dystrophy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6239894" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

